Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3

BACKGROUND: Recombinant von Willebrand factor (rVWF, vonicog alfa, Vonvendi/Veyvondi, Takeda Pharmaceuticals USA, Lexington, MA) and several plasma-derived VWF/factor VIII (pdVWF/FVIII) concentrates are available for treating bleeding episodes in patients with von Willebrand disease (VWD). PURPOSE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Alexander, Friberg-Hietala, Sofia, Smania, Giovanni, Wolfsegger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276593/
https://www.ncbi.nlm.nih.gov/pubmed/37332615
http://dx.doi.org/10.2147/JBM.S395845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276593/
https://www.ncbi.nlm.nih.gov/pubmed/37332615
http://dx.doi.org/10.2147/JBM.S395845

Ejemplares similares